HomeNews

News

  • Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Anticholinergic drugs can increase Dementia risk in patients, study finds

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Celgene to re-file Ozanimod in 1st quarter of 2019

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Amneal Initiates Phase 3 Study for IPX203 in Advanced Parkinson’s Disease Patients

    • May 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Esketamine improves outcomes in Treatment-Resistant Depression patients, new Phase 3 data shows

    • May 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Early detection of Alzheimer’s disease expected with the help of Body-worn sensors

    • May 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Technology to help Parkinson’s patients sleep through surgery

    • May 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Mavenclad has even greater treatment effect in Patients with Highly Active Multiple Sclerosis, shows latest data

    • May 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ocrevus reduces response of MS patients to Vaccines, claims latest study

    • May 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more